Skip to main content

Table 1 The clinical characteristics at baseline

From: Effects of statin therapy on chronic kidney disease patients with coronary artery disease

Variables CKD + CAD CKD P a
(n = 128) (n = 126)
Characteristics
 Age (years) 69.7 ± 8.4 53.6 ± 17.8 < 0.001
 Male 90/128 (70.3) 54/126 (42.8) < 0.001
 BMI (kg/m2) 24.3 ± 2.1 23.4 ± 2.2 0.001
 Hypertension 95/128 (74.2) 71/126 (56.3) 0.003
 Diabetes mellitus 34/128 (26.5) 36/126 (28.5) 0.72
 Smoking 58/128 (45.3) 21/126 (16.6) < 0.001
 Myocardial infarction 72/128 (56.2) 0/126 (0) < 0.001
 Angina pectoris 51/128 (39.8) 0/126 (0) < 0.001
 Stroke 7/128 (5.4) 6/126 (4.7) 0.798
Medications
 Calcium-channel blocker 45/128 (35.1) 64/126 (50.7) 0.012
 ACEI 57/128 (44.5) 23/126 (18.2) < 0.001
 ARB 46/128 (35.9) 66/126 (52.3) 0.008
β-blocker 92/128 (71.8) 37/126 (28.6) < 0.001
 Loop diuretic 19/128 (14.8) 11/126 (8.7) 0.131
 Aspirin 117/128 (91.4) 37/126 (29.3) < 0.001
 Statin 116/128 (90.6) 58/126 (46.0) < 0.001
  1. Data are presented as mean ± SD or the number and its percentage (%). Percentage = the number of each individual category divided by n
  2. CAD coronary artery disease, CKD chronic kidney disease, ACEI angiotensin-converting enzyme inhibitor, ARB angiotensin-receptor blocker, BMI body mass index
  3. a indicates the comparison of mean or percentage between CKD + CAD group and CKD group